0
0
10/6/22 at 7:05pm
Organization
Newswise
35 words
0
Comments
The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes.
You are the first to view
https://www.newswise.com/articles/tofacitinib-shows-promise-in-scleroderma-patients-researchers-optimistic-for-next-phase-of-study
Create an account
or login to join the discussion